Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 2
2007 1
2008 4
2009 5
2010 5
2011 13
2012 19
2013 29
2014 34
2015 32
2016 32
2017 27
2018 26
2019 16
2020 37
2021 41
2022 35
2023 29
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

347 results

Results by year

Filters applied: . Clear all
Page 1
Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19.
Pulito-Cueto V, Sebastián Mora-Gil M, Ferrer-Pargada D, Remuzgo-Martínez S, Genre F, Lera-Gómez L, Alonso-Lecue P, Batista-Liz JC, Tello-Mena S, Abascal-Bolado B, Izquierdo S, Ruiz-Cubillán JJ, Armiñanzas-Castillo C, Blanco R, González-Gay MA, López-Mejías R, Cifrián JM. Pulito-Cueto V, et al. Among authors: blanco r. Int J Mol Sci. 2024 Mar 27;25(7):3731. doi: 10.3390/ijms25073731. Int J Mol Sci. 2024. PMID: 38612539 Free PMC article.
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
Rua-Figueroa I, García de Yébenes MJ, Martinez-Barrio J, Galindo Izquierdo M, Calvo Alén J, Fernandez-Nebro A, Menor-Almagro R, Carmona L, Tejera Segura B, Tomero E, Freire-González M, Sangüesa C, Horcada L, Blanco R, Uriarte Itzazelaia E, Narváez J, Rosas Gómez de Salazar JC, Gómez-Sabater S, Morales CM, Andreu JL, Segarra VT, Aurrecoechea E, Perez A, Nóvoa Medina J, Salgado E, Lozano-Rivas N, Montilla C, Ruiz-Lucea E, Arevalo M, Iñiguez C, García-Villanueva MJ, Exposito L, Ibáñez-Barceló M, Bonilla G, Carrión-Barberà I, Erausquin C, Fragio Gil JJ, Pecondón A, Toyos FJ, Cobo T, Muñoz-Jiménez A, Oller J, Nolla JM, Pego-Reigosa JM. Rua-Figueroa I, et al. Among authors: blanco r. Lupus Sci Med. 2024 Apr 8;11(1):e001096. doi: 10.1136/lupus-2023-001096. Lupus Sci Med. 2024. PMID: 38589223 Free PMC article. Review.
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register.
Fernández-Lozano D, Hernández-Rodríguez I, Narvaez J, Domínguez-Álvaro M, De Miguel E, Silva-Díaz M, Belzunegui JM, Moriano Morales C, Sánchez J, Galíndez-Agirregoikoa E, Aldaroso V, Abasolo L, Loricera J, Garrido-Puñal N, Moya Alvarado P, Larena C, Navarro VA, Calvet J, Casafont-Solé I, Ortiz-Sanjuán F, Salman Monte TC, Castañeda S, Blanco R; ARTESER Project Collaborative Group. Fernández-Lozano D, et al. Among authors: blanco r. RMD Open. 2024 Mar 26;10(1):e003824. doi: 10.1136/rmdopen-2023-003824. RMD Open. 2024. PMID: 38531620 Free PMC article.
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Carter K, Stakias V, Lippe R, Drogaris L, Soliman AM, Chen MM, Padilla B, Kivitz A. Östör A, et al. Among authors: blanco r. Rheumatol Ther. 2024 Mar 18. doi: 10.1007/s40744-024-00657-2. Online ahead of print. Rheumatol Ther. 2024. PMID: 38498139 Free article.
Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry.
Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, Fernández-Fernández E, Silva-Díaz M, Valero JA, González I, Martín JS, Narváez J, Calvo I, Mendizábal J, Alcázar LA, Loricera J, Roman AR, Moya P, Cabañas MT, Estrada P, Prado FJ, Castañeda S, Blanco R. Molina-Collada J, et al. Among authors: blanco r. Rheumatology (Oxford). 2024 Jan 20:keae042. doi: 10.1093/rheumatology/keae042. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38244610
Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases.
Navarro-Compán V, Puig L, Vidal S, Ramírez J, Llamas-Velasco M, Fernández-Carballido C, Almodóvar R, Pinto JA, Galíndez-Aguirregoikoa E, Zarco P, Joven B, Gratacós J, Juanola X, Blanco R, Arias-Santiago S, Sanz JS, Queiro R, Cañete JD. Navarro-Compán V, et al. Among authors: blanco r. Front Immunol. 2023 Nov 22;14:1332177. doi: 10.3389/fimmu.2023.1332177. eCollection 2023. Front Immunol. 2023. PMID: 38077344 Free PMC article.
Features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitors.
Álvarez-Reguera C, Prieto-Peña D, Herrero-Morant A, Sánchez-Bilbao L, Batlle-López A, Fernández-Luis S, Paz-Gandiaga N, Blanco R. Álvarez-Reguera C, et al. Among authors: blanco r. Eur J Intern Med. 2024 May;123:102-106. doi: 10.1016/j.ejim.2023.11.019. Epub 2023 Dec 2. Eur J Intern Med. 2024. PMID: 38044168
347 results